Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

PloS one - 1 Jan 2012

Ardanuy Carmen, Marimón José María, Calatayud Laura, Giménez Montserrat, Alonso Marta, Grau Immaculada, Pallarés Román, Pérez-Trallero Emilio, Liñares Josefina

Abstract excerpt

BACKGROUND: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for adults. We analyzed the epidemiology of invasive pneumococcal disease (IPD) in older adults in Spain before PCV13 introduction. METHODOLOGY/PRINCIPAL FINDINGS: IPD episodes, defined as clinical findings together with an invasive pneumococcal isolate, were prospectively collected from patients aged over 65 years in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pneumococcal Infections

Share to Serotyping

Share to Streptococcus pneumoniae

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 22928005
DOI: 10.1371/journal.pone.0043619
PMCID: PMC3425535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.PMID 22928005Read ↗

Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.Semantic proximity Read ↗

Nationwide Surveillance of Invasive Pneumococcal Disease in Spain: Impact of Conjugate Vaccines and the COVID-19 Pandemic (2009-2023)Semantic proximity Read ↗

Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain.Semantic proximity Read ↗

Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil.Semantic proximity Read ↗

Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011Semantic proximity Read ↗

Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, BelgiumSemantic proximity Read ↗

Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study.Semantic proximity Read ↗

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022Semantic proximity Read ↗

Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infectionsSemantic proximity Read ↗

Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation.Semantic proximity Read ↗

Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.Semantic proximity Read ↗

Characteristics of pediatric invasive pneumococcal diseases and the pneumococcal isolates in Suzhou, China before introduction of PCV13.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.